WHSC News and 


WHSC News Releases for September

September 30, 2003  Emory Nursing Dean Marla Salmon To Deliver Fifth Annual Mary Lynn Morgan Lecture About the Silent Crisis of the Nursing Shortage
Marla Salmon, RN, ScD, FAAN, dean of Emory University’s Nell Hodgson Woodruff School of Nursing, will present "The Crisis in Caring: Nursing and the Failing Demographic Equation" at the Mary Lynn Morgan Annual Lectureship on Women in the Health Professions. The event will take place on Wednesday, October 8 at 7:30 p.m. in the Michael C. Carlos Museum Reception Hall on the Emory University campus. Parking is available in the Fishburne Parking Deck.
September 24, 2003 Gov. Perdue, Emory President Wagner Join in Winship Cancer Institute Dedication
Governor Sonny Perdue and Emory University President James Wagner will join patients and faculty in formally dedicating Emory's new Winship Cancer Institute today at 2 p.m. The ceremony will be held outdoors in front of the 280,000-square-foot building, which boasts research laboratories as long as football fields along with the most up-to-date facilities for cancer treatment. Tours and light refreshments will follow the dedication and ribbon cutting.
September 23, 2003 Emory Cardiothoracic Surgeons Use New CO2 Laser Technology To Relieve Symptoms of Severe Coronary Artery Disease
Despite receiving a variety of treatments for coronary artery disease -- ranging from coronary artery bypass surgery (CABG), coronary artery angioplasty and stents to medications -- many heart patients continue to suffer from the chest pain known as angina that occurs when the heart does not receive enough oxygen-rich blood. Cardiothoracic surgeons at Emory University Hospital (EUH) can now help many people with severe coronary artery disease who have run out of traditional options for relieving angina. The procedure, known as Transmyocardial Laser Revascularization (TMR), uses a new generation of laser technology -- the CO2 laser.
September 23, 2003 New ALS Genetics Research Study Underway at Emory University; ALS Center at Emory Offers Expertise to Patients Across Southeast
It is one of the most devastating disorders affecting the function of nerves and muscles in the body, according to the ALS Association. Amyotrophic lateral sclerosis (ALS) -- often referred to as Lou Gehrig’s disease -- slowly and progressively robs patients of muscle control and movement throughout the body. In the latter stages of the disease, muscles often become totally paralyzed. While cognitive function usually remains untouched, patients with ALS watch as their body withers away while their thinking is still clear ­ meaning these patients are aware of the disease that will eventually lead to their death.
September 22, 2003 Anti-HIV Drug Invented by Emory University Scientists Continues Development Through Pharmaceutical Collaboration
Incyte Corporation and Pharmasset, Ltd., have announced a licensing collaboration to continue development and commercialization of an anti-HIV drug invented by scientists at Emory University. The antiretroviral drug Reverset™, also known as RVT, D-D4FC or DPC-817 is currently in Phase IIa clinical trials and is targeted to HIV patients who have developed resistance to common antiretroviral drugs.
September 22, 2003 New Emory Center Offers Voice Care for Professional Speakers and Singers
From baritones to broadcasters, from salespersons to schoolteachers, millions of Americans depend on the normal functioning of their voices to win friends, influence people and bring home the bacon. Yet scores of factors ranging from poor vocal technique to diseases of the mouth and throat, can threaten our ability to speak or sing with confidence and authority.
September 19, 2003 Emory Mini-Medical School 102: Diagnosis and Treatment Decisions in Medicine
Rich with a host of new lecturers and topics, Emory University's popular Mini-Medical School 102 for the general public will run for five consecutive Tuesday nights, October 7, 2003 to November 4, 2003 from 7 to 9 p.m. This course picks up where the Mini-Medical School 101 course left off and includes an optional additional one-night "residency" that takes class members through Emory's Wesley Woods Geriatric Hospital.
September 19, 2003 Emory Crawford Long Hospital's New Cardiac MRI Provides Non-Invasive Look at Heart Function
Emory Crawford Long Hospital’s Carlyle Fraser Heart Center is utilizing the latest techniques to view detailed images of the heart, using magnetic resonance imaging, or an MRI, without subjecting patients to invasive tests.
September 18, 2003 Yerkes Researchers First To Recognize Sense Of Fairness In Nonhuman Primates
In the first experimental demonstration of its kind, researchers led by Sarah Brosnan and Frans de Waal, PhD, at the Yerkes National Primate Research Center of Emory University, and the Living Links Center, have shown nonhuman primates respond negatively to unequal reward distribution, a reaction often seen in humans based on their universal sense of fairness. While researchers have long recognized the sense of fairness within the human species, Brosnan and de Waal are the first to confirm this trait in nonhuman primates. The findings appear in the September 18 issue of Nature.
September 17, 2003 Emory University School of Medicine Receives $16 Million NIH Grant to Lead Biodefense Consortium Aimed at Vaccine Development
Emory University School of Medicine has received a grant of $16 million to lead one of five national Cooperative Centers for Translational Research on Human Immunology and Biodefense announced today by the National Institute of Allergy and Infectious Diseases (NIAID). Other institutions in the Emory center include the Institute for Systems Biology in Seattle, Washington; the Institute for Research in Biomedicine in Bellinzona, Switzerland, the Mayo Clinic, and the Centers for Disease Control and Prevention (CDC).
September 15, 2003 Former CDC Director to Lecture at Emory on "Plagues: Bugs and Behavior"
During a global public health career spanning nearly 30 years and addressing disease issues ranging from SARS to smoking, Jeffrey Koplan, MD has developed a unique perspective and understanding of global "plagues" that include infectious disease epidemics such as smallpox, pandemic flu, and HIV/AIDS, as well as chronic disease crises such as obesity and tobacco and alcohol-related illnesses.
September 11, 2003 Emory University School of Medicine Researchers Study Effects of Alcohol Abuse on Lungs Through $7 Million NIH Grant
As part of a recently launched study funded by a $7 million grant from the Alcohol Abuse and Alcoholism branch of the National Institutes of Health, researchers at Emory University Schoolof Medicine are working to combat acute respiratory distress syndrome (ARDS) and its association with chronic alcohol abuse. The five-year study is a collaboration with the Emory Alcohol and Lung Biology Center.
September 11, 2003 Emory Cardiologist Heads National DECREASE-HF Study To Find Best Cardiac Resynchronization Therapy Mode For Heart Failure Patients
Now a national study involving approximately 60 medical centers throughout the U.S., including Emory University Hospital (EUH) and Emory Crawford Long Hospital (ECLH), is researching the optimum way to program biventricular pacemakers to provide CHF patients with the best possible therapeutic benefits.
September 11, 2003 Emory Researchers Find Paxil Improves Memory and Brain Structure In Post-Traumatic Stress Disorder Sufferers
Emory University researchers have found that paroxetine HCL (Paxil) produces measurable improvement in verbal memory and also increases the size of the hippocampus, a key area of the brain involved in learning and remembering, in persons suffering from post-traumatic stress disorder (PTSD). Their study, which will be published in the Oct. 1 edition of Biological Psychiatry, also found that Paxil significantly reduces the three main symptom clusters of PTSD -- re-experiencing the traumatic event; avoidance and emotional numbing related to experiences that recall the traumatic event; and hyperarousal at inappropriate times.
September 4, 2003 Emory One of Six Southeastern Universities Leading New $45 Million Biodefense Program
Emory University is part of a six-university consortium named today to lead a new biodefense initiative developing the next generation of vaccines, drugs and diagnostic tests against emerging infections such as SARS, and for defense against organisms such as smallpox that might be used in bioterrorist attacks.
September 2, 2003 Emory's Winship Cancer Institute Earns $1.9 Million NCI Grant
Governor Sonny Perdue and Michael Johns, MD, executive vice president for Health Affairs and CEO of the Woodruff Health Sciences Center at Emory University, announced today that Emory’s Winship Cancer Institute (WCI) has been awarded a $1.9 million National Cancer Institute Planning Grant.


For more general information on The Robert W. Woodruff Health Sciences
Center, call The Health Sciences Communications Office at

404-727-5686, or send e-mail to hsnews@emory.edu

Copyright © Emory University, 2001. All Rights Reserved.